108
Views
19
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Secondary hematological malignancies after breast cancer chemotherapy

, , , , , , , & show all
Pages 1183-1188 | Received 28 Mar 2005, Published online: 03 Aug 2009

References

  • Weldon CB, Jeffe BM, Kahn MJ. Therapy-induced leukemias and myelodysplastic syndromes after breast cancer treatment: an underemphasized clinical problem. Ann Surg Oncol 2002;9:738— 744.
  • Curtis RE, Boice JD, Stovall M, et al. Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med 1992;326:1745–1751.
  • Obedian E, Fischer DB, Haffty BG. Second malignancies after treatment of early-stage breast cancer: lumpectomy and radiation therapy versus mastectomy. J Clin Oncol 2000;18:2406 — 2412.
  • Roy ES, John B, Arthur D et al. Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin— cyclophospha-mide adjuvant therapy for operable breast cancer: the national surgical adjuvant breast and bowel project experience. J Clin Oncol 2002;21:1195–1204.
  • Chaplain G, Milan C, Sgro C et al. Increased risk of acute leukemia after adjuvant chemotherapy for breast cancer: a population-based study. J Clin Oncol 2000;18:2836 — 2842.
  • Pedersen-Bjergaard J, Sigsgaard TC, Nielsen D et al. Acute monocytic or myelomonocytic leukemia with balanced chro-mosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer. J Clin Oncol 1992;10:1444–1451.
  • Pedersen-Bjergaard J, Philip P, Larsen SO et al. Therapy-related myelodysplasia and acute leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series. Leukemia 1993;7:1975 —1986.
  • Saso R, Kulkarni S, Mitchell P et al. Secondary myelodys-plastic syndrome/acute myeloid leukemia following mitoxantrone-based therapy for breast carcinoma. Br J Cancer 2000;83:91 —94.
  • Pedersen-Bjergaard J, Pedersen M, Roulston D et al. Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia. Blood 1995;86:3542 —3552.
  • Kroger N, Damon L, Zander AR et al. Secondary acute leukemia following mitoxantrone-based high-dose chemother-apy for primary breast cancer patients. Bone Marrow Transplantation 2003;32:1153 —1157.
  • Bernard-Marty C, Mano M, Paesmans C et al. Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophospha-mide, methotrexate and 5-fluorouracil (CMF) with an anthracycline-based regimen in adjuvant treatment of node-positive breast cancer patients. Ann Oncol 2003;14:693 —698.
  • Roussel M. Non-Hodgkin's lymphoma in women with breast cancer: a retrospective study of 46 patients. J Clin Oncol 2004;22(14S):6670.
  • Fisher B, Rockette H, Fisher ER et al. Leukemia in breast cancer patients following adjuvant chemotherapy or post-operative radiation: the NSABP experience. J Clin Oncol 1985;12:1640— 1658.
  • Haas JF, Kittelmann B, Mehner WH etal. Risk of leukemia in ovarian tumor and breast cancer patients following treatment by cyclophosphamide. Br J Cancer 1987;55:213 —218.
  • Curtis RE, Boice JD, Moloney WC et al. Leukemia following chemotherapy for breast cancer. Cancer Res 1990;50:2741 — 2746.
  • Valagussa P, Molitemi A, Terenziani M et al. Second malignancies following CMF-based adjuvant chemotherapy in resectable breast cancer. Ann Oncol 1996;5:803 — 808.
  • Diamandidou E, Buzdar AU, Smith TL et al. Treatment-related leukemia in breast cancer patients treated with fluorouracil — doxorubicin— cyclophosphamide combination adjuvant chemotherapy: the University of Texas M.D. Anderson Cancer Center experience. J Chin Oncol 1996;14:2722–2730.
  • Laughlin MJ, McGaughey DS, Crews JR et al. Secondary myelodysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplant. J Chin Oncol 1998;16:1008–1012.
  • Linassier C, Barin C, Calais G et al. Early secondary acute myelogenous leukemia in breast cancer patients after treat-ment with mitoxantrone, cyclophosphamide, fluorouracil and radiation therapy. Ann Oncol 2000;11:1289— 1294.
  • Kroger N, Zander AR, Martinelli Get al. European Group for Blood and Marrow Transplantation. Low incidence of secondary myelodysplasia and acute myeloid leukemia after high-dose chemotherapy as adjuvant therapy for breast cancer patients: a study by the Solid Tumors Working Party of the European Group for Blood and Marrow Transplantation. Ann Oncol 2003;14:554 — 558.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.